Beyond pharmaceuticals, J&J’s medical devices ... from the Abiomed acquisition (J&J acquired Abiomed in 2022). Our Procter & Gamble Revenue Comparison and Johnson & Johnson Revenue Comparison ...

Johnson & Johnson boasts a diversified business model across pharmaceuticals ... investors seeking stability and long-term growth. Procter & Gamble is a multinational consumer goods corporation ...

Coca-Cola plans to invest $1 billion in its Nigeria operations over the next five years, the country's presidency said after ...

"The company's strong position in both pharmaceuticals and med tech allows ... The company currently yields 2.4%. Procter & Gamble's biggest domestic competitor, Colgate-Palmolive, is also a ...

The stock market can feel like a roller coaster, especially during economic uncertainty. As fears of a recession increase, ...

Procter & Gamble Co. (NYSE: PG ... and markets veterinary pharmaceuticals, vaccines, health management solutions and services ...

At that point, I made the academia-to-industry conversion and began a 30-year career in R&D at Procter & Gamble. For the first 16 years, I was part of the Pharmaceuticals organization, eventually ...

Their innovative platform caters to a diverse range of industries including pharmaceuticals, biotechnology, agriculture, food and nutrition, as well as government and defense sectors. Founded in ...

In this article, we look at Unilever’s improved performance marked by a 25% ytd stock return and a return to positive volume ...

A good imagination and persistence are required. Medicinal and pharmaceutical chemists apply their chemistry training to the process of synthesizing new pharmaceuticals. They also improve the ...

Now showing summary data for the 2024 election cycle. Now showing data for the election cycle. The pharmaceutical and health products industry — including not only drug manufacturers but also dealers ...

From 1968 to 2020, Americans experienced a remarkable increase in life expectancy, from 70 to 78 years. Much of that was due to advances in drugs and vaccines, many of which are now unavailable ...